Sensitive, high-throughput analysis of lead in whole blood using the Agilent 7500cx ICP-MS with ISIS-DS

Significance of the Topic

Lead analysis in whole blood is critical due to the severe toxicity of lead and its health impacts. Accurate measurement at low concentrations requires minimal sample handling to avoid contamination and robust instrumentation to cope with complex biological matrices. High throughput and stability are essential for clinical and public health laboratories managing large sample volumes.

Objectives and Overview

This application note demonstrates the performance of the Agilent 7500cx ICP-MS equipped with the ISIS-DS discrete sampling system for rapid, sensitive, and stable quantification of lead in whole blood. The study follows a strict 50× dilution protocol based on the California Department of Public Health method and evaluates precision, detection limits, sample throughput, and long-term stability over more than 300 analyses.

Methodology and Instrumentation

The analytical method combines discrete sampling and inductively coupled plasma mass spectrometry under robust plasma conditions. Key features include:

• ICP-MS tuned for low oxide formation (CeO+/Ce+ ~1%) at 1550 W forward power
• ISIS loop (50 cm length, 0.8 mm id, 250 µL volume) with 20 s stabilization
• Sample introduction with 50× blood dilution in a diluent containing NH4OH, EDTA, 1-butanol, and Triton X-100
• Calibration with non-matrix matched standards (0–1 µg/dL Pb) yielding instrumental detection limit of 3.1 ppt

Key Results and Discussion

The method achieved an on-instrument detection limit of 5.4 × 10⁻⁴ µg/dL (5.4 ppt) and, accounting for a 50× dilution, an in-sample detection limit of 270 ppt. Repeat analysis of CADPH SRMs and QC samples (low, medium, high blood lead levels) over 301 runs demonstrated:

• High precision with %RSD typically below 2%
• Accurate recoveries of 97–100% for spiked and SRM samples
• Sample-to-sample cycle time of 52 s, enabling over 300 analyses in under 4.5 h
• Stable internal standard recoveries (193Ir and 103Rh) within 85–105% throughout the run

Benefits and Practical Applications

The Agilent 7500cx ICP-MS with ISIS-DS offers:

• Minimal maintenance due to reduced matrix loading
• Elimination of matrix-matched standards, simplifying calibration
• High throughput suited for clinical, public health, and research laboratories
• Robust performance in complex matrices, ensuring reliable long-term operation

Future Trends and Opportunities

Advances may include further optimization of sample dilution protocols, expansion to multi-element panels in blood, integration with automated sample preparation systems, and development of miniaturized or field-deployable ICP-MS platforms. Machine learning algorithms could enhance data processing, drift correction, and predictive maintenance.

Conclusion

Using the ISIS-DS with the Agilent 7500cx ICP-MS enables rapid, sensitive, and stable lead analysis in whole blood. The approach meets regulatory requirements, delivers high throughput, and reduces maintenance and calibration complexity, making it an attractive solution for diverse laboratory environments.

References

• Clinical and Laboratory Standards Institute C40-A Analytical Procedures for the Determination of Lead in Blood, 06/01/2001